Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up
EuroIntervention 2016;12:1498-1509 published online ahead of print October 2015. DOI: 10.4244/EIJY15M10_03
Shimpei Nakatani1, MD; Yohei Sotomi2, MD; Yuki Ishibashi1, MD, PhD; Maik J. Grundeken2, MD; Hiroki Tateishi1, MD, PhD; Erhan Tenekecioglu1, MD; Yaping Zeng1, MD, PhD; Pannipa Suwannasom1, MD; Evelyn Regar1, MD, PhD; Maria D. Radu3, MD, PhD; Lorenz Räber4, MD, PhD; Hiram Bezerra5, MD, PhD; Marco A. Costa5, MD, PhD; Peter Fitzgerald6, MD, PhD; Francesco Prati7,8, MD, PhD; Ricardo A. Costa9, MD, PhD; Jouke Dijkstra10, PhD; Takeshi Kimura11, MD, PhD; Ken Kozum
1. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 3. Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen
Aims: Fully bioresorbable Absorb poly-L-lactic-acid (PLLA) scaffolds (Abbott Vascular, Santa Clara, CA, USA) are a novel approach for the treatment of coronary narrowing. Due to the trans